Literatur
Beer E (1928) Periostitis and ostitis of the symphysis and rami of the pubis following suprapubic cystotomies. J Urol 20(2):233–236
Ziesel C, Frees S, Thomas C, Stein R, Gillitzer R, Thüroff JW (2016) Pubic symphysitis after transurethral resection of the prostate. World J Urol 34(2):275–280
Garg G, Deliso M, Li S, Sharma P, Abdelbaki A, Gupta N (2018) Prostatosymphyseal fistula after transurethral resection of the prostate (TURP), a rare and difficult to recognize complication. Urol Case Rep 21:70–72
Elshout PJ, Verleyen P, Putzeys G (2015) Osteitis pubis after TURP: a rare complication difficult to recognize. Urol Case Rep 4:55–56
Whelan L, Mullarkey E, Woo HH (2015) Prostatosymphyseal fistula treated by robotic assisted radical prostatectomy. Case Rep Urol 2015:582705
Plateau B, Ruivard M, Montoriol PF (2015) Prostatosymphyseal fistula and osteomyelitis pubis following transurethral resection of the prostate: CT and MRI findings. J Med Imaging Radiat Oncol 59(6):713–715
Gillitzer R, Melchior SW, Jones J, Fichtner J, Thüroff JW (2001) Prostatosymphyseal fistula after transurethral resection of the prostate. J Urol 166(3):1001–1002
Gerullis H, Eitzen A, Uphoff J et al (2017) Recurrent symphysitis culminating in pelvic ring fracture after hyperextended transurethral prostate resection and vaporization with symphysis erosion: a case report. J Med Case Rep 11(1):141
Davis NF, Torregiani W, Thornhill J (2016) Osteitis pubis after standard bipolar TURP surgery: insight into aetiology, diagnosis, management and prevention of this rarity. BMJ Case Rep 2016:bcr2015212420
Steinbach HL, Petrakis NL, Gilfillan RS, Smith DR (1955) The pathogenesis of osteitis pubis. J Urol 74(6):840–846
Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF (2019) Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis 81:128–136
Füllhase C (2016) Transurethral resection of the prostate. Urologe A 55(11):1433–1439
Gilfrich C, Leicht H, Fahlenbrach C, Jeschke E, Popken G, Stolzenburg JU, Weißbach L, Zastrow C, Günster C (2016) Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database. Prostate Cancer Prostatic Dis 19(4):406–411
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50(5):969–979 (discussion 980)
Wilhelm K, Cazana IM, Schoenthaler M, Katzenwadel A, Spaeth J, Miernik A (2018) Low-pressure monopolar electroresection of the prostate for glands sized 〉 70 vs. 〈 70 cc performed with continuous irrigation and suprapubic suction: perioperative and long-term outcome. World J Urol 36(3):449–457
Alexander CE, Scullion MM, Omar MI, Yuan Y, Mamoulakis C, N’Dow JM, Chen C, Lam TB (2019) Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009629.pub4
Bschleipfer T, Oelke M, Rieken M (2019) Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : an overview. Urologe A 58(3):238–247
Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109
Choo MS, Yoo C, Cho SY, Jeong SJ, Jeong CW, Ku JH, Oh SJ (2017) Development of decision support formulas for the prediction of bladder outlet obstruction and prostatic surgery in patients with lower urinary tract symptom/benign prostatic Hyperplasia: part I, development of the formula and its internal validation. Int Neurourol J 21(Suppl 1):S55–65
Magistro G, Stief CG, Gratzke C (2019) Novel minimally invasive treatment options for male lower urinary tract symptom. Urologe A 58(3):254–262
Schöb DS, Reichelt AC, Gross AJ, Abt D, Miernik A, Gratzke C (2020) Neue operative Techniken zur Therapie des benignen Prostatasyndroms [Novel surgical techniques for treatment of benign prostatic hyperplasia]. Urologe A. 59(3):347–358. https://doi.org/10.1007/s00120-020-01149-1. PMID: 32072200
Nguyen DD, Barber N, Bidair M et al (2020) Waterjet ablation therapy for endoscopic resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates. BJU Int 125(1):112–122
Elterman D, Bach T, Rijo E et al (2020) Transfusion rates after 800 Aquablation procedures using various haemostasis methods. BJU Int. https://doi.org/10.1111/bju.14990
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Haccius, C. Gilfrich und M. May geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.
The supplement containing this article is not sponsored by industry.
Additional information
Redaktion
U. Necknig, Garmisch-Partenkirchen
M. S. Michel, Mannheim
Rights and permissions
About this article
Cite this article
Haccius, M., Gilfrich, C. & May, M. 67/m mit Becken- und Leistenschmerzen nach transurethraler Prostataresektion. Urologe 59 (Suppl 2), 202–208 (2020). https://doi.org/10.1007/s00120-020-01354-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-020-01354-y